Macular Degeneration Animation

Age-related macular degeneration (AMD) is a disease that affects the macula.




Macular Degeneration cross-section imageAbout macular degeneration.

The macula is the part of the eye that allows us to see fine detail. When the macula is damaged, the central vision may become blurry, distorted or dark.

The macula is located on the retina, the light-sensitive, back, inner lining of the inside of the eye. A healthy macula gives us the sharp, central vision we need for “straight-ahead” activities such as driving or reading.

Macular Degeneration is the result of gradual deterioration of the tissues in the macula. When the macula is damaged, the central vision may become blurry, distorted or dark.



AMD is typically classified into two general types: Dry and Wet. More than 8 out of 10 cases of macular degeneration fall into the “Dry” classification.

Dry AMD occurs when the light-sensitive cells in the macula slowly break down over time. Debris from the pigment layer and surrounding tissues accumulates and forms deposits called drusen. The presence of drusen is the first sign of early, DRY AMD. Early symptoms can range from undetectable, to blurring and distortion of the central vision. In the advanced stages of this painless disease, complete central vision loss can occur.

Wet AMD, is more serious than Dry. This form of macular degeneration occurs when the accumulating drusen cause inflammation. The inflamed cells release growth factors which cause abnormal blood vessels to form under the retina. These fragile vessels leak fluid and blood into the layers of the macula, which is where the term “wet” macular degeneration came from. Wet AMD can lead to rapid decrease in vision and if left untreated, can cause permanent vision loss.

There are several options available to retinal specialists for the treatment of wet AMD. Currently, there are no FDA approved treatments for dry macular degeneration. However, most eye doctors will offer a proactive plan with numerous preventative measures, including lifestyle adjustments and nutritional recommendations, all aimed at slowing the progression of this vision-robbing eye disease.

Lucentis Eye Injection

Lucentis eye injection is a treatment for macular degeneration




Lucentis eye injection treatment for macular degeneration and vein occlusion

Wet macular degeneration is one of the most common causes of blindness, Lucentis eye injection is a treatment.

Lucentis eye injection is a modern treatment for wet AMD, which develops in about 1 in 10 cases of macular degeneration. Above is a video explaining how Lucentis eye injection is used to treat wet macular degeneration. There are two types of macular degeneration: dry and wet macular degeneration. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred vision or distorted vision. Without treatment, vision loss may be quick and severe.

The patient should consult their retina specialist / ophthalmologist about signs and symptoms of Lucentis side effects. Lucentis is an eye injection drug given by an eye surgeon. It is better and more effective than traditional laser eye surgery because it does not leave scarring in the macular central portion of vision. Lucentis was developed by Genentech and it is widely used for wet macular degeneration.



Lucentis side effects

Lucentis eye injection for treatment of macular degeneration has very few and rare side effects. The possibility of infection is extremely important to understand and the patient should consult their retina specialist / ophthalmologist about signs and symptoms of Lucentis side effects.

Other uses for Lucentis eye injection

Recently, Lucentis was approved for retinal vein occlusion and diabetic macular edema. These are two eye conditions that can cause profound vision loss. Adding Lucentis eye injection to the vitreo-retina doctor’s arsenal is a big advancement in the retina eye care field.

Diabetic macular edema is one of the leading causes of vision loss in the world. It is caused by weakened and leaky capillaries in the retinal vascular system, due to diabetes.

Retinal vein occlusion can also cause macular edema. This condition, also known as cystoid macular edema, as responded well to Lucentis eye injection. Lucentis is now a mainstream treatment for these two eye conditions.